Market revenue in 2023 | USD 139.5 million |
Market revenue in 2030 | USD 187.6 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.32% in 2023. Horizon Databook has segmented the Middle East & Africa implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The ICD market in the MEA is growing rapidly due to the high prevalence of cardiac diseases. With more people suffering from cardiovascular conditions, the demand for effective monitoring and treatment options like ICDs is growing rapidly.
Moreover, increased Research and Development (R&D) expenditure in the region is supported by government funding. For instance, in 2020, the UAE allocated 1.3% of its GDP to R&D, and the Abu Dhabi Government invested USD 1.09 billion in healthcare R&D.
This investment fosters innovation and advancements in medical technologies, including ICD devices. The significant funding of USD 10.89 million for 53 research projects in 2021 across various sectors also shows the commitment of MEA governments to advance medical technologies. These efforts are expected to further drive growth in the MEA ICD market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account